Cargando…
Inhibitory effects of brusatol delivered using glycosaminoglycan-placental chondroitin sulfate A-modified nanoparticles on the proliferation, migration and invasion of cancer cells
Breakthroughs in cancer management result from the development of drugs that can be used for early diagnosis and effective treatment. Surgery, chemotherapy, radiotherapy and hormone therapy are the main anticancer therapies. However, traditional cancer chemotherapy is associated with serious systemi...
Autores principales: | Chen, Xin, Yin, Tailang, Zhang, Baozhen, Sun, Beini, Chen, Jie, Xiao, Tianxia, Wang, Baobei, Li, Mengxia, Yang, Jing, Fan, Xiujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307823/ https://www.ncbi.nlm.nih.gov/pubmed/32626948 http://dx.doi.org/10.3892/ijmm.2020.4627 |
Ejemplares similares
-
Screening and surveillance of multiple solid tumours using plasma placental-like chondroitin sulfate A (pl-CSA)
por: Zhang, Juzuo, et al.
Publicado: (2020) -
Urinary sulfated glycosaminoglycan insufficiency and chondroitin sulfate supplement in urolithiasis
por: Dissayabutra, Thasinas, et al.
Publicado: (2019) -
Uncoupling of chondroitin sulfate glycosaminoglycan synthesis by brefeldin A
Publicado: (1991) -
Glycosaminoglycan Domain Mapping of Cellular Chondroitin/Dermatan Sulfates
por: Persson, Andrea, et al.
Publicado: (2020) -
Site-specific identification of heparan and chondroitin sulfate glycosaminoglycans in hybrid proteoglycans
por: Noborn, Fredrik, et al.
Publicado: (2016)